Home › Non-Hodgkin Lymphoma › Connecticut
Non-Hodgkin Lymphoma clinical trials in Connecticut
8 studies for Non-Hodgkin Lymphoma are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Yale University School of Medicine - Yale Cancer Center, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Saint Vincent's Medical Center (SVMC), Bridgeport
- Hartford Hospital, Hartford
- Midstate Medical Center (MSMC), Meriden
- and 4 more
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
- Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
- Clinical Trial Site, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06393738Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
- Yale University, New Haven
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06116110DALY II USA/ MB-CART2019.1 for DLBCL
- Yale University, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Yale New Haven Hospital, New Haven
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.